EMERGENCY MANAGEMENT OF HYPERGLYCEMIA

Main Article Content

Nabeel Jaber Alharbi
Amany Mohammad Mohammad Sahli
Rawiyah Mohammed Buayti
Mossa Shadad Abdullh Hakami
Khaled Mohammed Nasser Awlaqi
Abdulrahman Yahya Salem Almalk
Hossam Mohammed Ahmed Rayyani
Nasser Mohammed Nasser Dhamda
Salem Mohammed Ahmed Bajunayd
Fahad Yousef Jaber Ammari
Marei Mohammed Malhan
Amal Musa Jebreel
Nouf Mohammed A Aboishah
Mousa Hamod Nehary Hagawi
Naif Mohammed Jaber Kalufah

Keywords

Emergency Department, Hyperglycemia, Diabetic ketoacidosis, insulin therapy, Hyper osmolality

Abstract

Background: Hyperglycemia is frequent in emergency departments due to various stressors such as pain, trauma, infection, or diabetes. Emergency room patients with diabetes have the highest incidence of hyperglycemia, with 30-40% being diabetic. In general wards, hyperglycemia occurs in 30-40% of patients, rising to 80% in intensive care units. Prolonged elevated blood sugar levels can lead to significant organ damage in the kidneys, cardiovascular system, extremities, and eyes.This review highlights the various management therapies for patients with hyperglycemia admitted to the emergency department.

Abstract 402 | PDF Downloads 120

References

1. Association AD: Standards of Medical Care in Diabetes—2014. Diabetes Care. 2013, 37:S14-S80. 10.2337/dc14-S014
2. Davies MJ, D’Alessio DA, Fradkin J, et al.: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018, 41:2669-2701. 10.2337/dci18-0033
3. Golovchenko I, Goalstone ML, Watson P, Brownlee M, Draznin B: Hyperinsulinemia enhances transcriptional activity of nuclear factor-κB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells. Circulation research. 2000, 87:746-752.
4. Wang J, Geiss LS, Williams DE, Gregg EW: Trends in emergency department visit rates for hypoglycemia and hyperglycemic crisis among adults with diabetes, United States, 2006-2011. PloS one. 2015, 10:e0134917.
5. Menke A, Casagrande S, Geiss L, Cowie CC: Prevalence of and trends in diabetes among adults in the United States, 1988-2012. Jama. 2015, 314:1021-1029.
6. Ginde AA, Cagliero E, Nathan DM, Camargo CA: Value of risk stratification to increase the predictive validity of HbA1c in screening for undiagnosed diabetes in the US population. Journal of general internal medicine. 2008, 23:1346-1353.
7. Charfen MA, Ipp E, Kaji AH, Saleh T, Qazi MF, Lewis RJ: Detection of undiagnosed diabetes and prediabetic states in high‐risk emergency department patients. Academic Emergency Medicine. 2009, 16:394-402.
8. Ginde AA, Savaser DJ, Camargo Jr CA: Limited communication and management of emergency department hyperglycemia in hospitalized patients. Journal of Hospital Medicine: An Official Publication of the Society of Hospital Medicine. 2009, 4:45-49.
9. Echouffo-Tcheugui JB, Garg R: Management of hyperglycemia and diabetes in the emergency department. Current diabetes reports. 2017, 17:1-8.
10. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN: Hyperglycemic crises in adult patients with diabetes. Diabetes care. 2009, 32:1335.
11. Kitabchi AE, Umpierrez GE, Murphy MB, et al.: Management of hyperglycemic crises in patients with diabetes. Diabetes care. 2001, 24:131-153.
12. Umpierrez GE, Latif K, Stoever J, et al.: Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. The American journal of medicine. 2004, 117:291-296.
13. Luzi L, Barrett EJ, Groop LC, Ferrannini E, DeFronzo RA: Metabolic effects of low-dose insulin therapy on glucose metabolism in diabetic ketoacidosis. Diabetes. 1988, 37:1470-1477.
14. Goyal N, Miller JB, Sankey SS, Mossallam U: Utility of initial bolus insulin in the treatment of diabetic ketoacidosis. The Journal of emergency medicine. 2010, 38:422-427.
15. Umpierrez GE, Jones S, Smiley D, et al.: Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial. Diabetes care. 2009, 32:1164-1169.
16. Adrogué HJ, Lederer ED, Suki WN, Eknoyan G: Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine. 1986, 65:163-172.
17. Winter RJ, Harris CJ, Phillips LS, Green OC: Diabetic ketoacidosis: induction of hypocalcemia and hypomagnesemia by phosphate therapy. The American journal of medicine. 1979, 67:897-900.
18. Magee MF, Nassar CM, ye Mete M, White K, Youssef GA, Dubin JS: The synergy to enable glycemic control following emergency department discharge program for adults with type 2 diabetes: step-diabetes. Endocrine Practice. 2015, 21:1227-1239.
19. Chung N, Rascati K, Lopez D, Jokerst J, Garza A: Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population. Journal of Managed Care Pharmacy. 2014, 20:914-919.

Most read articles by the same author(s)